Prenatal probiotic administration can influence Bifidobacterium microbiota development in infants at high risk of allergy

Journal of Allergy and Clinical Immunology

Volumn 123, Issue 2, 2009, Pages

  Lahtinen, Sampo J ^a,b,d   Boyle, Robert J ^a,b,c   Kivivuori, Satu ^a   Oppedisano, Frances ^a   Smith, Katherine R ^a   Robins Browne, Roy ^b   Salminen, Seppo J ^d   Tang, Mimi L K ^a,b,c  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; MALTODEXTRIN; PLACEBO; PROBIOTIC AGENT;

ALLERGIC DISEASE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; BREAST MILK; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HIGH RISK INFANT; HUMAN; INTESTINE FLORA; LACTOBACILLUS RHAMNOSUS; LETTER; NEWBORN; NORMAL HUMAN; PATIENT COMPLIANCE; PRENATAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN SENSITIZATION;

EID: 59449100312     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.11.034     Document Type: Letter

References (10)

1. Suzuki S., Shimojo N., Tajiri Y., Kumemura M., and Kohno Y. Differences in the composition of intestinal Bifidobacterium species and the development of allergic diseases in infants in rural Japan. Clin Exp Allergy 37 (2007) 506-511
2. Stsepetova J., Sepp E., Julge K., Vaughan E., Mikelsaar M., and de Vos W.M. Molecularly assessed shifts of Bifidobacterium ssp. and less diverse microbial communities are characteristic of 5-year-old allergic children. FEMS Immunol Med Microbiol 51 (2007) 260-269
3. Björksten B., Sepp E., Julge K., Voor T., and Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 108 (2001) 516-520
4. Kalliomäki M., Kirjavainen P., Eerola E., Kero P., Salminen S., and Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 107 (2001) 129-134
5. Kalliomäki M., Salminen S., Arvilommi H., Kero P., Koskinen P., and Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357 (2001) 1076-1079
6. Osbourne D.A., and Sinn J. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev (2007) CD006475
7. Gueimonde M., Sakata S., Kalliomäki M., Isolauri E., Benno Y., and Salminen S. Effect of maternal consumption of Lactobacillus GG on transfer and establishment of fecal bifidobacterial microbiota in neonates. J Pediatr Gastroenterol Nutr 42 (2006) 166-170
8. Gueimonde M., Tölkkö S., Korpimäki T., and Salminen S. New real-time quantitative PCR procedure of quantification of Bifidobacterium in human fecal samples. Appl Environ Microbiol 70 (2004) 4165-4169
9. Ouwehand A.C., Isolauri E., He F., Hashimoto H., Benno Y., and Salminen S. Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol 108 (2001) 144-145
10. Schultz M., Gottl C., Young R.J., Iwen P., and Vanderhoof J.A. Administration of oral probiotic bacteria to pregnant women causes temporary infantile colonization. J Pediatr Gastroenterol Nutr 38 (2004) 293-297